|
CCDC52 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.259400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.169810E-02 |
| Normal-vs-Stage2 |
5.773900E-04 |
| Normal-vs-Stage3 |
1.522290E-03 |
| Normal-vs-Stage4 |
6.398200E-03 |
| Stage1-vs-Stage2 |
1.088200E-01 |
| Stage1-vs-Stage3 |
1.232570E-01 |
| Stage1-vs-Stage4 |
3.797200E-01 |
| Stage2-vs-Stage3 |
6.740200E-01 |
| Stage2-vs-Stage4 |
4.140200E-01 |
| Stage3-vs-Stage4 |
6.791200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.004900E-03 |
| Normal-vs-AfricanAmerican |
8.069000E-01 |
| Normal-vs-Asian |
2.537400E-03 |
| Caucasian-vs-AfricanAmerican |
9.061700E-02 |
| Caucasian-vs-Asian |
5.115000E-01 |
| AfricanAmerican-vs-Asian |
4.642400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.836000E-02 |
| Normal-vs-Female |
6.985500E-04 |
| Male-vs-Female |
2.089400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.110000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.563300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.858470E-03 |
| Normal-vs-Age(81-100Yrs) |
1.886290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.613800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.016400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.548300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.390400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.318800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.147200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.759800E-04 |
| Classical-VS-Follicular |
8.476600E-01 |
| Classical-VS-Other |
9.787600E-01 |
| Classical-VS-Normal |
1.759640E-02 |
| Tall-VS-Follicular |
1.847850E-02 |
| Tall-VS-Other |
9.455500E-02 |
| Tall-VS-Normal |
3.36550000001878E-06 |
| Follicular-VS-Other |
9.679000E-01 |
| Follicular-VS-Normal |
3.967800E-02 |
| Other-VS-Normal |
2.816000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.202940E-03 |
| Normal-vs-N1 |
2.118300E-03 |
| N0-vs-N1 |
6.240600E-01 |
|
|
